Amedisys EPS beats by $0.25, revenue in-line

Amedisys  (NASDAQ:AMED): Q3 Non-GAAP EPS of $1.15 beats by $0.25; GAAP EPS of $1.03 beats by $0.15.

Revenue of $494.63M (+18.5% Y/Y) in-line.

Press Release

https://seekingalpha.com/news/3511054-amedisys-and-nbsp-eps-beats-0_25-revenue-line